Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults infected with HIV: a phase III trial

被引：0

作者：

Mohapi, L. ^{[1
]}

Osiyemi, O. ^{[2
]}

Supparatpinyo, K. ^{[3
]}

Ratanasuwan, W. ^{[4
]}

Molina, J. ^{[5
]}

Dagan, R. ^{[6
]}

Tamms, G. ^{[7
]}

Sterling, T. ^{[7
]}

Zhang, Y. ^{[7
]}

Hartzel, J. ^{[7
]}

Pedley, A. ^{[7
]}

Kan, Y. ^{[7
]}

Hurtado, K. ^{[7
]}

Buchwald, U. ^{[7
]}

Musey, L. ^{[7
]}

Simon, J. ^{[7
]}

机构：

[1] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa

[2] Triple O Res Inst, Infect Dis, W Palm Beach, FL USA

[3] Chiang Mai Univ, Dept Internal Med, Chiang Mai, Thailand

[4] Mahidol Univ, Dept Prevent & Social Med, Siriraj Hosp, Nakhon Pathom, Thailand

[5] Assistance Publ Hop Paris, Infect Dis, Paris, France

[6] Ben Gurion Univ Negev, Pediat Infect Dis Unit, Beer Sheva, Israel

[7] Merck & Co Inc, Clin Res, Kenilworth, NJ USA

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2020年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

O443

引用

页码：16 / 16

页数：1

共 50 条

[1] Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV
Mohapi, Lerato
Pinedo, Yvett
Osiyemi, Olayemi
Supparatpinyo, Khuanchai
Ratanasuwan, Winai
Molina, Jean-Michel
Dagan, Ron
Tamms, Gretchen
Sterling, Tina
Zhang, Ying
Pedley, Alison
Hartzel, Jon
Kan, Yanqing
Hurtado, Kim
Musey, Luwy
Simon, Jakub K.
Buchwald, Ulrike K.
[J]. AIDS, 2022, 36 (03) : 373 - 382
[2] Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine (PCV), in adults infected with human immunodeficiency virus (HIV): a phase 3 trial
Spowart, Laura
Mohapi, Lerato
Osiyemi, Olayemi
Supparatpinyo, Khuanchai
Ratanasuwan, Winai
Molina, Jean-Michel
Dagan, Ron
Tamms, Gretchen
Sterling, Tina
Zhang, Ying
Pedley, Alison
Kan Yanqing
Hurtado, Kim
Buchwald, Ulrike
Musey, Luwy
Simon, Jakub
[J]. HIV MEDICINE, 2021, 22 : 3 - 4
[3] A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants
Platt, Heather L.
Greenberg, David
Tapiero, Bruce
Clifford, Robert A.
Klein, Nicola P.
Hurley, David C.
Shekar, Tulin
Li, Jianing
Hurtado, Kim
Su, Shu-Chih
Nolan, Katrina M.
Acosta, Camilo J.
McFetridge, Richard D.
Bickham, Kara
Musey, Luwy K.
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (08) : 763 - 770
[4] A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV
Wilck, Marissa
Barnabas, Shaun
Chokephaibulkit, Kulkanya
Violari, Avy
Kosalaraksa, Pope
Yesypenko, Svitlana
Chukhalova, Iryna
Dagan, Ron
Richmond, Peter
Mikviman, Elena
Morgan, Leslie
Feemster, Kristen
Lupinacci, Robert
Chiarappa, Joseph A.
Madhi, Shabir
Bickham, Kara
Musey, Luwy
[J]. AIDS, 2023, 37 (08) : 1227 - 1237
[5] Safety and Immunogenicity of V114, a 15-valent Pneumococcal Conjugate Vaccine, Compared with 13-valent Pneumococcal Conjugate Vaccine in Japanese Adults Aged ≥65 Years: Subgroup Analysis of a Randomized Phase III Trial (PNEU-AGE)
Kishino, Hiroyuki
Sawata, Miyuki
Igarashi, Rie
Shirakawa, Masayoshi
Pedley, Alison
Musey, Luwy
Platt, Heather Loryn
Buchwald, Ulrike Kirsten
[J]. JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2022, 75 (06) : 575 - 582
[6] A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)
Platt, Heather L.
Cardona, Jose F.
Haranaka, Miwa
Schwartz, Howard, I
Perez, Silvia Narejos
Dowell, Anthony
Chang, Chih-Jen
Dagan, Ron
Tamms, Gretchen M.
Sterling, Tina
Morgan, Leslie
Shi, Yaru
Pedley, Alison
Musey, Luwy K.
Buchwald, Ulrike K.
[J]. VACCINE, 2022, 40 (01) : 162 - 172
[7] Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study
Quinn, Charles T.
Wiedmann, Richard T.
Jarovsky, Daniel
Lopez-Medina, Eduardo
Rodriguez, Hilze M.
Papa, Melanie
Boggio, Gordana
Shou, Qiong
Dagan, Ron
Richmond, Peter
Feemster, Kristen
McFetridge, Richard
Tamms, Gretchen
Lupinacci, Robert
Musey, Luwy
Bickham, Kara
[J]. BLOOD ADVANCES, 2023, 7 (03) : 414 - 421
[8] Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A phase III study (V114-033)
Suzuki, Hiroko
Fujita, Hidetoshi
Iwai, Kazuyuki
Kuroki, Haruo
Taniyama, Kazuhiko
Shizuya, Toshiyuki
Kishino, Hiroyuki
Igarashi, Rie
Shirakawa, Masayoshi
Sawata, Miyuki
[J]. VACCINE, 2023, 41 (34) : 4933 - 4940
[9] Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults
McFetridge, Richard
Meulen, Ajoke Sobanjo-ter
Folkerth, Steven D.
Hoekstra, John A.
Dallas, Michael
Hoover, Patricia A.
Marchese, Rocio D.
Zacholski, Donna M.
Watson, Wendy J.
Stek, Jon E.
Hartzel, Jonathan S.
Musey, Luwy K.
[J]. VACCINE, 2015, 33 (24) : 2793 - 2799
[10] Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)
Severance, Randall
Schwartz, Howard
Dagan, Ron
Connor, Laurie
Li, Jianing
Pedley, Alison
Hartzel, Jonathan
Sterling, Tina M.
Nolan, Katrina M.
Tamms, Gretchen M.
Musey, Luwy K.
Buchwald, Ulrike K.
[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01) : 1 - 14

← 1 2 3 4 5 →